Late right heart failure (RHF) is increasingly recognized in patients with long-term left
ventricular assist device (LVAD) support and is associated with decreased survival and …

The treatment of end-stage heart failure has evolved substantially with advances in medical
treatment, cardiac transplantation, and mechanical circulatory support (MCS) devices such …

The medical management of patients supported with durable continuous flow left ventricular
assist device (LVAD) support encompasses pharmacological therapies administered in the …

Introduction: Heart failure (HF) is a severe and terminal stage of various heart diseases. Left
ventricular assist devices (LVADs) are relatively mature and have contributed to the …

Left ventricular assist devices (LVADs) are an increasingly used strategy for the
management of patients with advanced heart failure. Although these devices effectively …

Objective To compare 3-year survival and readmissions of patients who received the
HeartMate 3 (HM3) left ventricular assist device (LVAD) or underwent orthotopic heart …

Background Outcomes of patients with implanted left ventricular assist device (LVAD)
implantation experiencing a cardiac arrest (CA) are not well reported. We aimed at defining …

Abstract Background and Objective The series type of LVAD (ie, BJUT-II VAD) is a novel left
ventricular assist device, whose effects on the aortic valve remain unclear. Methods The …

Left ventricular assist devices (LVADs) are an increasingly used strategy for the
management of patients with advanced heart failure. Although these devices effectively …

This chapter is developed with the intention of discussing the use of implantable defibrillator
cardioverters (ICDs) in patients with left ventricular assist devices (LVADs). LVADs have …